The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery
about
Magnetographic array for the capture and enumeration of single cells and cell pairs.Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsetsHIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Impact of illicit opioid use on T cell subsets among HIV-infected adults.Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial.Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort StudyNeurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid.A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV.CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapyCD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART.Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy.A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?Blood pressure responses after resistance exercise session in women living with human immunodeficiency virus/acquired immunodeficiency syndromeMonitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals?
P2860
Q30426598-2C7F9B74-7A8F-4428-BDBE-67D1A11CA932Q30807586-B0FB8E0E-C3EA-4C29-9230-61C12BA81129Q33591190-9B3B9AB6-6187-4C04-A6F3-3A1AFD5027BCQ33618542-EE160991-E62D-4D70-977A-1FB2BC2D0443Q33637866-E38F5209-0B29-4AC2-BC12-6A03FE8D6822Q33919900-672AE1CF-B171-487A-8E8E-93DE97283728Q35814594-C30F7EF0-D7C3-4294-AB8E-1B459B6A782EQ36072424-7EF36F0E-67CC-4E44-8363-B3654D2328B2Q36259851-B2C200D1-E193-4080-B53D-2DDD495A032BQ36671999-76A831E4-912A-4979-907E-4F15DEDCA0D1Q37364956-7CB12459-A5B0-40F5-B011-1C29E823C6DEQ37534052-D36E0A5C-5267-4CAC-8C74-7D22100D71ACQ39093640-7962A8E9-A5B1-4B8E-A0DD-BC8FC39BFFDAQ40043083-D3408756-1536-489C-949C-003E771BFF66Q40070123-B6F0EDE2-4B7B-4394-8A56-A52139832438Q40294920-DE1D3E69-5003-42E7-ADD3-0F6E99588F1FQ40463006-7DD7CB9B-97AA-4D5C-B301-744893B5D0C6Q40531468-7C4566BF-8E74-4C3A-B7F1-E0E6BE761CF4Q40779840-21385D66-8BC1-4AF3-BBCF-F2B20F6766A0Q40932221-1CCE2A84-40DC-4299-9C7B-51C4D5131D57Q40989476-23D787A4-AB5D-4855-9824-70FAEF7F5E01Q41454338-42DC125D-29E6-4EDE-BDC4-A606256A9AD6Q47141455-A0835CC0-6CA1-48AC-96DF-5E72F0486870Q57132186-B5028B00-6B48-4AB6-862C-6726DE045B8DQ59118545-7F8EA2F4-1928-4873-BE94-CC1F33B51079
P2860
The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@ast
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@en
type
label
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@ast
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@en
prefLabel
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@ast
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
The CD4:CD8 ratio is associate ...... ts with immunological recovery
@en
P2093
A Fernández-Cruz
N G P de Villar
P2860
P3181
P356
10.1111/HIV.12081
P577
2013-09-06T00:00:00Z